Physician profile
Imran Amir
NPI 1891815247
$5,908.00
in general payments reported to CMS, 2019-2025
18 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $224 · 2021: $139 · 2022: $3,600 · 2023: $844 · 2024: $521 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,781.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $3,391.24 | 2022 | |
| Merz North America, INC. | $892.33 | 2020-2024 | Xeomin |
| Amgen INC. | $455.82 | 2022-2024 | Otezla |
| Dermavant Sciences, INC. | $170.06 | 2024 | Vtama |
| Abbvie INC. | $147.79 | 2019-2025 | Rinvoq |
| Apyx Medical Corporation | $143.69 | 2019 | |
| Janssen Biotech, INC. | $114.44 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $89.63 | 2021-2024 | |
| Pfizer INC. | $76.57 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $74.05 | 2023-2024 | Zoryve |
| Almirall LLC | $72.04 | 2025 | Seysara |
| Sun Pharmaceutical Industries INC. | $66.85 | 2022-2025 | |
| Genzyme Corporation | $55.32 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $49.67 | 2024-2025 | Sotyktu |
| Organon LLC | $41.27 | 2025 | Vtama |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $34.93 | 2024 | |
| Ucb, INC. | $18.61 | 2025 | Bimzelx |
| Leo Pharma INC. | $13.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Amir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.